Browsing: health

Corza Medical, a global leader in medical technology, has launched its latest innovation in ophthalmic surgery at the American Academy of Ophthalmology (AAO) conference in Chicago. The new product, Onatec ophthalmic microsurgical sutures, represents a significant step forward in eye care, designed to meet the evolving needs of surgeons and improve patient outcomes. The announcement, made at the annual AAO event held from 18th to 21st October 2024, was welcomed by eye care professionals eager to explore the new offering. Onatec sutures have been developed to provide exceptional performance during delicate eye surgery, ensuring minimal trauma to tissues while enhancing…

King Faisal Specialist Hospital & Research Centre (KFSHRC) has announced its participation as a Platinum Sponsor in the upcoming Global Health Exhibition 2024, taking place in Riyadh from October 21 to 23. The hospital will feature a pavilion showcasing its latest health innovations and solutions, aimed at improving healthcare outcomes, enhancing patient experience, and boosting operational efficiency. KFSHRC’s exhibition will highlight several cutting-edge medical advancements, including robotic heart surgery, organ transplantation, CAR-T cell production, and pharmacogenomic analysis. Additionally, the hospital will introduce its capacity command centre and its notable achievements in employing virtual reality within medical education. The hospital’s involvement…

Kyowa Kirin International (KKI) has announced the upcoming presentation of interim findings from three significant real-world studies focusing on cutaneous T-cell lymphoma (CTCL) at the European Organisation for Research and Treatment of Cancer’s Cutaneous Lymphoma Tumour Group (EORTC-CLTG) annual meeting. The event is set to take place in Lausanne, Switzerland, from 9 to 11 October 2024. These studies involve participants from Europe, the United States, and the United Arab Emirates, and aim to gather evidence regarding the effectiveness of mogamulizumab, a pioneering humanised monoclonal antibody therapy. This treatment is currently approved in Europe and the UAE for adult patients with…

AscellaHealth, a leading global partner in customisable solutions for the specialty pharmaceutical industry, has announced its role as Gold Sponsor of the upcoming World Orphan Drug Congress Europe (WODC). The event is scheduled to take place from 22nd to 25th October 2024 in Barcelona, Spain. The WODC is renowned as the largest and most established conference dedicated to orphan drugs and rare diseases worldwide. This annual gathering brings together industry leaders, healthcare professionals, and stakeholders to discuss advancements in orphan drug development and strategies for enhancing patient access to therapies. AscellaHealth will showcase its comprehensive suite of end-to-end solutions, designed…

A Warwick man has been given a second chance at life thanks to his dog, who alerted him to an aggressive cancerous tumour that required extensive surgery. Mark Allen, 65, underwent a 10-hour operation to remove the tumour from his nose and subsequently faced a major facial reconstruction. Mark, a father of two, ignored troubling symptoms for nearly a year, which allowed the tumour to spread across the right side of his face. He recalls how his dog Jessie began behaving unusually, clinging to him and acting in a way that made him suspect something was wrong. “I couldn’t breathe…

The Foundation Fighting Blindness, a global leader in research for blinding retinal diseases, has announced a significant expansion of its donation platforms. In partnership with The Giving Block, the Foundation now accepts donor-advised funds (DAFs) and stock donations, while also introducing cryptocurrency as a donation method. This move aims to simplify the process for donors and attract new contributors worldwide. Jeff Klaas, the chief strategy and innovation officer at the Foundation, said the expansion reflects the organisation’s commitment to embracing modern technologies. “By enhancing our giving platforms, we are making it easier for donors to support our research through donor-advised…

Endo, Inc. has unveiled new clinical data on collagenase clostridium histolyticum (CCH) for treating plantar fibromatosis at the American Orthopaedic Foot & Ankle Society’s (AOFAS) annual scientific meeting, which is being held through September 14, 2024. The Phase 2 clinical trial, presented orally at the conference, examined the efficacy of CCH in patients with plantar fibromatosis, also known as Ledderhose disease. The study, a double-blind, randomised, placebo-controlled trial, aimed to evaluate CCH’s impact compared to a placebo in alleviating the condition’s symptoms. Dr. James P. Tursi, Executive Vice President of Global Research & Development at Endo, emphasised the significance of…

Boots Online Doctor Revolutionizing Healthcare In recent years, the landscape of healthcare has shifted significantly, driven by the demand for more accessible and convenient medical services. One of the pioneers in this transformation is Boots, a well-known British pharmacy chain, through their service. This service provides access to consultations, prescriptions, and treatments without the need for an in-person visit to a GP. In this article, we will explore how the Boots Online Doctor service works, the benefits it offers, and how it fits into the broader trend of telemedicine. What is Boots Online Doctor Boots Online Doctor is a digital…

Rigaku Corporation, part of the Rigaku Holdings Group, has unveiled a groundbreaking technology named Electron Density Topography (EDT), poised to revolutionise the study of biological macromolecules. Headquartered in Akishima, Tokyo, and led by President and CEO Jun Kawakami, Rigaku’s latest innovation promises significant advancements in the field of X-ray analysis, with the potential to transform research and development processes for biopharmaceuticals. The new EDT technology, for which patents are pending, offers unprecedented clarity in observing the structure and dynamic characteristics of complex biological macromolecules such as antibodies, protein complexes, and virus particles. Unlike traditional methods that often introduce measurement artifacts,…

A new study has revealed that more than half of UK adults find their weight loss goals derailed by even a single setback, with nearly one in five abandoning their efforts entirely when faced with challenges. The research, commissioned by Slimming World, the largest weight-loss organisation in the UK and Ireland, surveyed 2,003 adults and sheds light on the significant hurdles people face in their attempts to shed pounds. According to the findings, 77 per cent of adults in the UK have attempted to lose weight at some point, with the average person trying seven times in their lifetime. Yet,…